This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • FDA approves Opdivo + Yervoy for first-line treatm...
News

FDA approves Opdivo + Yervoy for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L.- BMS

Read time: 1 mins
Last updated:18th May 2020
Published:17th May 2020
Condition: Non Small Cell Lung Cancer
Type: drug
Register now for full access to medthority.com